Related Experiment Video
Updated: May 22, 2026

RhoC GTPase Activation Assay
Published on: August 22, 2010
Rho GDP-dissociation inhibitor alpha is associated with cancer metastasis in colon and prostate cancer
T Yamashita1, T Okamura, K Nagano
1Laboratory of Biopharmaceutical Research, National Institute of Biomedical Innovation, Graduate School of Pharmaceutical Sciences Osaka University, Osaka, Japan.
Abstract:
Since metastasis is one of the most important prognostic factors in colorectal cancer, development of new methods to diagnose and prevent metastasis is highly desirable. However, the molecular mechanisms leading to the metastatic phenotype have not been well elucidated. In this study, a proteomics-based search was carried out for metastasis-related proteins in colorectal cancer by analyzing the differential expression of proteins in primary versus metastasis focus-derived colorectal tumor cells. Protein expression profiles were determined using a tissue microarray (TMA), and the results identified Rho GDP-dissociation inhibitor alpha (Rho GDI) as a metastasis-related protein in colon and prostate cancer patients. Consequently, Rho GDI may be useful as a diagnostic biomarker and/or a therapeutic to prevent colon and prostate cancer metastasis.
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The Ras Gene
Ras is a superfamily...
Activation and Inactivation of G Proteins
GPCRs Regulate Adenylyl Cylase Activity
Two...
GTPases and their Regulation
Large G-proteins, also known...

